Insider trading research with Taiwanese vaccine makers reveals broader issues
bernardblack, 02 July 2021
A survey of insider trading with Taiwan’s Covid-19 vaccine maker raised concerns about Taiwan’s fiscal oversight and involved President Tsai Ing-wen’s administration.
The Taipei-based Shilin District prosecutor’s office said Medigen Vaccine Biologics Corporation after the company’s stake jumped more than 20% in the days before announcing positive results for a phase II vaccine trial in June. He told the Financial Times that he was investigating. The prosecution refused to reveal the details of the investigation. Continue reading “Article: Insider trading research with Taiwanese vaccine makers reveals broader issues”
